Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.31 |
| ▸ | MLNR | O43193 | 1/20 | 0.30 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.30 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.30 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.30 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
| ▸ | DRD1 | P21728 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12014671 | 0.97 | PDK2 (0.36) | PDK2MEN1THRBRECQLBLM | |
| SCHEMBL13615640 | 0.97 | PDK2 (0.37) | PDK2MLNRNR1I2CHRM2ADRB1 | |
| SCHEMBL12648902 | 0.97 | PDK2 (0.36) | PDK2MEN1THRBRECQLBLM | |
| SCHEMBL15081534 | 0.95 | PDK2 (0.38) | PDK2 | |
| SCHEMBL13758036 | 0.95 | PDK2 (0.38) | PDK2 | |
| SCHEMBL12770706 | 0.95 | PDK2 (0.35) | PDK2MEN1THRBRECQLBLM | |
| SCHEMBL15002906 | 0.94 | PDK2 (0.36) | PDK2 | |
| SCHEMBL15002907 | 0.94 | PDK2 (0.36) | PDK2 | |
| SCHEMBL10304791 | 0.94 | PDK2 (0.39) | PDK2 | |
| SCHEMBL15002914 | 0.94 | PDK2 (0.36) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10273404-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2019-04-30 | — | — | US | disclosed |
| US-8877356-B2 | OLED device with stabilized yellow light-emitting layer | GLOBAL OLED TECHNOLOGY LLC (US) | 2014-11-04 | — | — | US | disclosed |
| US-8877356-B2 | OLED device with stabilized yellow light-emitting layer | GLOBAL OLED TECHNOLOGY LLC (US) | 2014-11-04 | — | — | US | disclosed |
| EP-2456617-B1 | OLED DEVICE WITH STABILIZED YELLOW LIGHT-EMITTING LAYER | GLOBAL OLED TECHNOLOGY LLC (US) | 2014-07-02 | — | — | EP | disclosed |
| US-20120326602-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2012-12-27 | — | — | US | disclosed |
| US-20120326602-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2012-12-27 | — | — | US | disclosed |
| US-20120217449-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2012-08-30 | — | — | US | disclosed |
| US-20120217449-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2012-08-30 | — | — | US | disclosed |
| WO-2011110276-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2011-09-15 | — | — | WO | disclosed |
| WO-2011054442-A2 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2011-05-12 | — | — | WO | disclosed |
| US-20110018429-A1 | OLED DEVICE WITH STABILIZED YELLOW LIGHT-EMITTING LAYER | GLOBAL OLED TECHNOLOGY LLC | 2011-01-27 | — | — | US | disclosed |
| WO-2011011501-A1 | OLED DEVICE WITH STABILIZED YELLOW LIGHT-EMITTING LAYER | GLOBAL OLED TECHNOLOGY LLC (US) | 2011-01-27 | — | — | WO | disclosed |
| US-20110018429-A1 | OLED DEVICE WITH STABILIZED YELLOW LIGHT-EMITTING LAYER | GLOBAL OLED TECHNOLOGY LLC | 2011-01-27 | — | — | US | disclosed |
| US-20100072888-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-03-25 | — | — | US | disclosed |
| US-20100072888-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-03-25 | — | — | US | disclosed |
| US-20100019657-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-01-28 | — | — | US | disclosed |
| US-20090091242-A1 | HOLE-INJECTING LAYER IN OLEDS | GLOBAL OLED TECHNOLOGY LLC | 2009-04-09 | — | — | US | disclosed |
| US-20090091242-A1 | HOLE-INJECTING LAYER IN OLEDS | GLOBAL OLED TECHNOLOGY LLC | 2009-04-09 | — | — | US | disclosed |
| US-20070134512-A1 | Electroluminescent device containing an anthracene derivative | EASTMAN KODAK COMPANY | 2007-06-14 | — | — | US | disclosed |
| US-20070134512-A1 | Electroluminescent device containing an anthracene derivative | EASTMAN KODAK COMPANY | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100072888-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | AOC2, SCO2, C1S | PDK2 2258/4885MEN1 2728/4885THRB 3882/4885 |
| US-20120217449-A1 | MATERIALS FOR ELECTRONIC DEVICES | EFNA1, DDT, ERCC1 | PDK2 1029/4885MEN1 171/4885THRB 4672/4885 |
| US-20100019657-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, ODC1 | PDK2 1591/4885MEN1 1902/4885THRB 4737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.